Institutional investors purchased a net $1.2 million shares of VYNE during the quarter ended June 2019, and now own 37.62% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 1.2 Million shares of Vyne Therapeutics Inc
U.S. BANK NA (CINCINNATI OHIO IN... Bought 4.4 Thousand shares of Vyne Therapeutics Inc
GEODE CAPITAL MANAGEMENT LLC Bought 2.6 Thousand shares of Vyne Therapeutics Inc